Jagsonpal Pharmaceuticals Ltd

NSE: JAGSNPHARM · BSE: 507789 · Pharmaceuticals & Biotechnology · 45 announcements

Share price: ₹235.40
Market cap: ₹1,553 Cr
Revenue (annual): ₹287.2 Cr
Net profit (annual): ₹43.08 Cr
P/E (TTM): 34.1×Sector 47.3×
Promoter holding: 69.05%+1.16% QoQ
FII holding: 2.30%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Merger & Restructuring 11 Employee Stock Options 9 Financial Results 4 Earnings Call 4 Annual General Meeting 4 Management Change 3 Other Announcement 2 Dividend 2 Board Meeting Outcome 2 Results Update 1 Business Update 1 Board Meeting Date 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

27 Apr 2026 20:05 IST NSE

Dividend

Jagsonpal Pharmaceuticals Dividend

Jagsonpal Pharmaceuticals Limited has recommended a dividend of Rs. 4/- (200%) per equity share for the financial year ended March 31, 2026. The dividend is subject to shareholder approval at the upcoming 47th Annual General Meeting. Record and payment dates will be announced separately.

Read the filing ↗

27 Apr 2026 19:58 IST NSE

Dividend

Jagsonpal Pharmaceuticals Dividend

Jagsonpal Pharmaceuticals Limited recommended a final dividend of ₹4 per equity share for the financial year. The record date and AGM date will be announced subsequently upon finalization. This recommendation is subject to shareholder approval at the upcoming Annual General Meeting.

Read the filing ↗